Literature DB >> 2453430

Hepatocellular carcinoma in type I glycogen storage disease.

J Limmer1, W E Fleig, D Leupold, R Bittner, H Ditschuneit, H G Beger.   

Abstract

Patients suffering from Type I glycogen storage disease frequently develop hepatic tumors. Some of these were classified as carcinoma, with the majority of tumors representing benign adenomata. However, no evidence exists of malignant transformation of adenomata in these patients. Here, we describe the occurrence of a hepatocellular carcinoma in the adenomata-bearing liver of the elder of two sisters suffering from Type I glycogen storage disease at the age of 20 years, 6 years after the diagnosis had been made. Surprisingly, alpha-fetoprotein levels were normal throughout the entire course of this patient, whereas the younger sister had elevated levels despite the absence of malignant lesions. Thus, the clinical significance of alpha-fetoprotein remains unclear in both cases. Nocturnal feeding, although performed continuously over the 6 years after the diagnosis, had obviously failed to prevent the development of hepatic tumors in both patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453430     DOI: 10.1002/hep.1840080317

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.

Authors:  Li-Ya Chiu; Priya S Kishnani; Tzu-Po Chuang; Cheng-Yang Tang; Cheng-Yuan Liu; Deeksha Bali; Dwight Koeberl; Stephanie Austin; Keri Boyette; David A Weinstein; Elaine Murphy; Adam Yao; Yuan-Tsong Chen; Ling-Hui Li
Journal:  J Gastroenterol       Date:  2013-10-16       Impact factor: 7.527

Review 3.  [Liver resection and transplantation for hepatic tumors].

Authors:  H Lang; C E Broelsch
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

Review 4.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 5.  Pathogenesis of hepatitis B virus infection.

Authors:  F V Chisari; M Isogawa; S F Wieland
Journal:  Pathol Biol (Paris)       Date:  2010-02-08

6.  Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia.

Authors:  L Faivre; D Houssin; J Valayer; J Brouard; M Hadchouel; O Bernard
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

7.  High Incidence of Serologic Markers of Inflammatory Bowel Disease in Asymptomatic Patients with Glycogen Storage Disease Type Ia.

Authors:  Nicole T Lawrence; Tayoot Chengsupanimit; Laurie M Brown; David A Weinstein
Journal:  JIMD Rep       Date:  2015-06-21

8.  Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I.

Authors:  Richard D Beegle; Laurie M Brown; David A Weinstein
Journal:  JIMD Rep       Date:  2014-10-12

Review 9.  The hepatic glycogen storage diseases--problems beyond childhood.

Authors:  P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.